UICC staging is a standardized way to describe how far a cancer has spread in the body. It is commonly based on the TNM system, which summarizes the primary tumor, lymph nodes, and distant metastasis. Clinicians use it worldwide to communicate cancer extent clearly and consistently. It helps align diagnosis, treatment planning, and research across hospitals and countries.
AJCC staging is a standardized way to describe how far a cancer has grown and spread. It is most commonly used for many solid tumors, such as cancers of the breast, lung, colon, and melanoma. Clinicians use AJCC staging to communicate clearly, plan care, and compare outcomes across patients and centers. It is published by the American Joint Committee on Cancer (AJCC) and is updated periodically.
Tumor-Node-Metastasis is a standardized way clinicians describe how far a cancer has spread. It summarizes the primary tumor, lymph node involvement, and distant spread. It is commonly used in solid tumors to assign a cancer “stage.” Staging helps organize diagnosis, treatment planning, and communication across care teams.
TNM staging is a standardized way to describe how far a solid tumor cancer has spread in the body. It summarizes the **T**umor size/extent, nearby **N**ode involvement, and distant **M**etastasis. TNM staging is commonly used in oncology clinics, pathology reports, and multidisciplinary cancer conferences. It helps clinicians communicate clearly about cancer extent at diagnosis and after treatment.
Oocyte preservation means collecting and freezing eggs (oocytes) for possible future use. It is a form of fertility preservation used when a person may lose ovarian function or fertility. In oncology, it is commonly discussed before treatments that can harm the ovaries. It may also be used for non-cancer reasons, such as delaying childbearing for personal or medical circumstances.
Sperm banking is the collection and freezing of sperm for possible future use in reproduction. It is also called sperm cryopreservation. It is commonly used before cancer treatment that may affect fertility. It may also be used before certain surgeries, medical therapies, or life events that could reduce sperm quality.
Cryopreservation is the controlled freezing and storage of living cells, tissues, or reproductive material at very low temperatures. It is used to pause biological activity so the material can be used later. In cancer care, it is commonly used for fertility preservation and for storing cells or tissue for transplant, research, or specialized therapies.
Oncofertility is the area of medicine that connects cancer care with reproductive medicine. It focuses on preserving the ability to have a biological child when cancer treatment may affect fertility. It is commonly used in oncology clinics, fertility centers, and survivorship programs. It can apply to children, adolescents, and adults of any sex who are starting or receiving cancer therapy.
Fertility preservation is a set of medical options used to help protect the ability to have a biological child in the future. It is most often discussed before cancer treatment, because chemotherapy, radiation, and some surgeries can affect reproductive organs. It may also be used before treatment for certain non-cancer conditions that can harm fertility. Care is typically coordinated between oncology and reproductive medicine teams.
Tumor lysis prophylaxis is a set of steps used to prevent tumor lysis syndrome during cancer treatment. Tumor lysis syndrome happens when many cancer cells break down quickly and release their contents into the blood. This prevention approach is most commonly used in blood cancers starting chemotherapy or other fast-acting therapies. It can also be used in selected solid tumors when the risk of rapid tumor breakdown is higher.